122 related articles for article (PubMed ID: 7975460)
21. Differential serological diagnosis of HTLV-I and HTLV-II infection by external membrane protein peptide-based enzyme immunoassays.
Lee HH; Shih J; O'Donnell D; Swanson P; Mann T; Allain JP
Clin Diagn Virol; 1997 May; 8(1):9-16. PubMed ID: 9248654
[TBL] [Abstract][Full Text] [Related]
22. Reliability of a screening assay for the simultaneous detection of antibodies to HIV-1/2 and HTLV-I/II.
Gómez-Hernando C; Gutiérrez M; Toro C; Soriano V
Vox Sang; 1996; 70(2):119-20. PubMed ID: 8801762
[No Abstract] [Full Text] [Related]
23. HTLV infection in ELISA-negative blood donors.
Zehender G; Girotto M; De Maddalena C; Francisco G; Moroni M; Galli M
AIDS Res Hum Retroviruses; 1996 May; 12(8):737-40. PubMed ID: 8744584
[TBL] [Abstract][Full Text] [Related]
24. Transfusion-transmitted retrovirus infection.
Williams AE; Sullivan MT
Hematol Oncol Clin North Am; 1995 Feb; 9(1):115-36. PubMed ID: 7737937
[TBL] [Abstract][Full Text] [Related]
25. [Prevalence and prognostic significance of anti-HTLV-I and anti-HIV-2 antibodies in patients with HIV infection in the Roman region].
Antinori A; Tamburrini E; Ventura G; Nervo P; Ortona L
Boll Ist Sieroter Milan; 1988; 67(5-6):345-50. PubMed ID: 2908738
[TBL] [Abstract][Full Text] [Related]
26. Absence of HTLV-1/2 infection among HCV-infected patients with no HIV-1/2 infection in Spain.
Vallejo A; Loza E; Mateos ML
J Clin Virol; 2015 Mar; 64():72-3. PubMed ID: 25728082
[No Abstract] [Full Text] [Related]
27. Human T lymphotropic virus types I- and II-specific antibody-dependent cellular cytotoxicity: strain specificity and epitope mapping.
Zhang XQ; Yang L; Ho DD; Kuritzkes DR; Chen IS; Ching WT; Chen YM; Schooley RT
J Infect Dis; 1992 May; 165(5):805-12. PubMed ID: 1373751
[TBL] [Abstract][Full Text] [Related]
28. Immunologic correlates of spontaneous lymphocyte proliferation in human T-lymphotropic virus infection.
Prince HE; Lee H; Jensen ER; Swanson P; Weber D; Fitzpatrick L; Doyle M; Kleinman S
Blood; 1991 Jul; 78(1):169-74. PubMed ID: 1676916
[TBL] [Abstract][Full Text] [Related]
29. Seroepidemiology of HTLV-I/II in universal screening of blood donations in France.
Couroucé AM; Pillonel J; Lemaire JM; Maniez M; Brunet JB
AIDS; 1993 Jun; 7(6):841-7. PubMed ID: 8103342
[TBL] [Abstract][Full Text] [Related]
30. [Current situation of human immunodeficiency virus type 2 and Human T lymphotropic virus in Spain].
Treviño A; Soriano V;
Enferm Infecc Microbiol Clin; 2010; 28(7):442-5. PubMed ID: 20570417
[TBL] [Abstract][Full Text] [Related]
31. Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides.
Horal P; Hall WW; Svennerholm B; Lycke J; Jeansson S; Rymo L; Kaplan MH; Vahlne A
Proc Natl Acad Sci U S A; 1991 Jul; 88(13):5754-8. PubMed ID: 1712105
[TBL] [Abstract][Full Text] [Related]
32. Evidence of serological cross-reactivities with human immunodeficiency virus types 1 and 2 and human T-lymphotropic virus types I and II in sera of pregnant women in Ibadan, Nigeria.
Olaleye DO; Ekweozor CC; Sheng Z; Rasheed S
Int J Epidemiol; 1995 Feb; 24(1):198-203. PubMed ID: 7797344
[TBL] [Abstract][Full Text] [Related]
33. Discovery and significance of new human T-lymphotropic viruses: HTLV-3 and HTLV-4.
Bagossi P; Bander P; Bozóki B; Tözsér J
Expert Rev Anti Infect Ther; 2009 Dec; 7(10):1235-49. PubMed ID: 19968515
[TBL] [Abstract][Full Text] [Related]
34. HTLV infection among foreign pregnant women living in Spain.
Treviño A; Benito R; Caballero E; Ramos JM; Parra P; Roc L; Eiros JM; Aguilera A; García J; Cifuentes C; Marcaida G; Rodríguez C; Trigo M; Arroyo LA; de Mendoza C; de Lejarazu RO; Soriano V
J Clin Virol; 2011 Oct; 52(2):119-22. PubMed ID: 21782504
[TBL] [Abstract][Full Text] [Related]
35. Stable human T-lymphotropic virus type I carrier rates for 7 years among a teenaged blood donor cohort of 1986 in Kumamoto, Japan.
Oguma S; Imamura Y; Kusumoto Y; Nishimura Y; Yamaguchi K; Takatsuki K; Okuma M
Leuk Res; 1995 Aug; 19(8):567-71. PubMed ID: 7658703
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of selected versus random blood donor screening for anti-HTLV-I antibodies.
Vrielink H; van der Poel CL; Reesink HW
Vox Sang; 1995; 68(4):251-2. PubMed ID: 7660648
[No Abstract] [Full Text] [Related]
37. Immune responsiveness to the immunodominant recombinant envelope epitopes of human T lymphotropic virus types I and II in diverse geographic populations.
Buckner C; Roberts CR; Foung SK; Lipka J; Reyes GR; Hadlock K; Chan L; Gongora-Biachi RA; Hjelle B; Lal RB
J Infect Dis; 1992 Nov; 166(5):1160-3. PubMed ID: 1383353
[TBL] [Abstract][Full Text] [Related]
38. The human HTLV-3 and HTLV-4 retroviruses: new members of the HTLV family.
Mahieux R; Gessain A
Pathol Biol (Paris); 2009 Mar; 57(2):161-6. PubMed ID: 18456423
[TBL] [Abstract][Full Text] [Related]
39. HTLV-II subtype b among injecting drug users in Spain.
Vallejo A; García-Sáiz A
Vox Sang; 1994; 67(1):81-2. PubMed ID: 7975462
[No Abstract] [Full Text] [Related]
40. Human T-cell lymphotropic virus antibody prevalence in HIV-1-infected individuals attending a sexual health clinic in South-East London.
Cooke FJ; Geretti AM; Zuckerman M
J Med Virol; 2005 Jun; 76(2):143-5. PubMed ID: 15834880
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
